Novartis India Plans Strategic Acquisitions and Expansion into Tier 2 and Tier 3 Markets, ETPharma
New Delhi: Pharma company Novartis India Ltd (NIL) plans to pursue disciplined, therapy-aligned acquisitions and deepen its last-mile…
Browsing Tag